Enzyme inhibitors - PDFSEARCH.IO - Document Search Engine

Enzyme inhibitors
Results: 115

#	Item
51	Pharmaceuticals and Medical Devices Safety Information No. 316 September 2014 Executive Summary Published by Pharmaceutical and Food Safety Bureau, Add to Reading List Source URL: www.pmda.go.jp Language: English - Date: 2014-09-30 20:35:39 Angiotensin-converting enzyme Pharmaceutical drug Biology Medicine ACE inhibitors Pharmacology Metronidazole
52	egu_logo_without_circle_grey Add to Reading List Source URL: www.biogeosciences.net Language: English - Date: 2014-12-03 10:51:45 Catalysis Enzyme kinetics Enzyme inhibitors Metabolism Enzyme Uncompetitive inhibitor Non-competitive inhibition Competitive inhibition Michaelis–Menten kinetics Chemistry Physical chemistry Enzymes
53	CALIFORNIA STATE SCIENCE FAIR 2014 PROJECT SUMMARY Name(s) Pooja A. Sheladiya Add to Reading List Source URL: www.usc.edu Language: English - Date: 2014-04-25 17:09:50 Enzymes Food colorings Monoamine oxidase inhibitors Hydrogen peroxide Turmeric Enzyme kinetics Enzyme Peroxide Reaction rate Chemistry Catalysis Chemical kinetics
54	Bioactive peptides from vegetable proteins María Cristina Añón Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), CONICET- Universidad Nacional de La Plata Add to Reading List Source URL: www.jst.go.jp Language: English - Date: 2009-09-17 00:30:26 Proteins Medicine Peptidase Endocrinology Peptide Peptide hormones Angiotensin-converting enzyme Angiotensin Amaranth Chemistry Biology ACE inhibitors
55	MDA DMD Clinical Research Network NCH IRB09[removed]Compare efficacy of the angiotensin converting enzyme inhibitor (ACEi) lisinopril with angiotensin II receptor antagonist (ARB) losartan for the cardiomyopathy of DMD Add to Reading List Source URL: currents.plos.org Language: English - Date: 2013-12-12 17:28:07 Organic chemistry Muscular dystrophy Enantiopure drugs Heart diseases Losartan Lisinopril Angiotensin II receptor antagonist Duchenne muscular dystrophy Heart failure Chemistry Health ACE inhibitors
56	Medicaid Non-Reform Health Plans Specifications for Year 3 Performance Measures Measure: Use Angiotensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Receptor Blockers (ARB) Therapy (ACE) Description: Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2008-12-09 15:18:27 Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson Healthcare Effectiveness Data and Information Set Managed care Medicaid AIDS HIV Antiretroviral drug Health Medicine HIV/AIDS
57	Medicaid Reform Health Plans Specifications for Year 3 Performance Measures Measure: Use Angiotensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Receptor Blockers (ARB) Therapy (ACE-pp) Description: Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2008-12-09 14:59:57 Healthcare reform in the United States Presidency of Lyndon B. Johnson Healthcare Effectiveness Data and Information Set Managed care Medicaid Disease management Smoking cessation Asthma Fraction Health Medicine Federal assistance in the United States
58	Adherence to angiotensin-converting enzyme inhibitors in incident chronic kidney disease patients Changchun Wang, MS1, Wendy St. Peter, PharmD, FCCP1,2, Jiannong Liu, PhD1, Frank Daniels, BS1, David Gilbertson, PhD1, All Add to Reading List Source URL: www.usrds.org Language: English - Date: 2006-11-06 09:02:10 Health Kidney diseases Organ failure Chronic kidney disease Medical prescription Compliance Medicine Pharmacology Pharmaceutical sciences
59	Boehringer Ingelheim Pharmaceuticals, Inc. Tipranavir Capsules NDA[removed]Antiviral Drugs Advisory Committee Briefing Document, April 19, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-05-18 11:35:39 Tipranavir Antiretroviral drug Ritonavir Saquinavir Lopinavir Tenofovir Enzyme inhibitor Zidovudine Efavirenz Chemistry Organic chemistry Protease inhibitors
60	[removed] Enzyme Kinetics: The study of reaction rates. For the 1st-order reaction S P the Velocity (V) is: Add to Reading List Source URL: home.cc.umanitoba.ca Language: English - Date: 2013-09-25 11:10:57 Chemical kinetics Catalysis Metabolism Enzyme inhibitors Enzyme kinetics Michaelis–Menten kinetics Enzyme Competitive inhibition Regulatory enzymes Chemistry Physical chemistry Enzymes